Diabetes-related amputations remain a serious and unequal burden in the United States. Here’s what recent CDC data and the 2025–2026 ADA Standards of Care say about who is at risk, what warning signs to watch for, and which prevention steps can lower the chance of losing a toe, foot, or leg.
Wildfire smoke is affecting air quality far beyond fire zones. Here’s how PM2.5 harms the lungs and heart, how to use the Air Quality Index (AQI) on AirNow, and what CDC and OSHA recommend to protect families and outdoor workers.
A practical, evidence-based checklist for U.S. households to prepare for respiratory virus season and disasters that interrupt care, based on CDC and federal emergency guidance.
Adults 65 and older remain at highest risk for severe COVID-19. Here’s what the CDC and FDA say about the 2025–2026 vaccine update, how well it protects against hospitalization, and how Medicare covers the cost.
Drug shortages remain a nationwide issue in early 2026. Here’s what it means when a medication appears on the FDA’s Drug Shortages list, how shortages differ from recalls, and what patients should do to protect their care.
The FDA has issued recent safety communications about compounded versions of popular GLP-1 drugs such as semaglutide and tirzepatide, warning of dosing errors, ingredient differences, and potential contamination. Here’s what patients and families should understand about the risks, legal limits, and how to protect themselves.
The American Diabetes Association’s 2026 Standards of Care update national guidance on glucose monitoring, medications, heart and kidney protection, and mental health screening. Here’s what changed — and what it means for patients across the United States.
As spring and summer approach, federal health agencies are reminding Americans that skin cancer is largely preventable. Here’s what the CDC, FDA, USPSTF, and National Cancer Institute say about UV exposure, sunscreen safety, and who should take extra precautions.
The Indian Health Service plans to phase out mercury-containing dental amalgam fillings in its facilities by 2027. Here’s what federal agencies say about safety, who may be at higher risk, and whether patients need to remove existing fillings.
Anti-amyloid antibody treatments such as lecanemab are now part of Alzheimer’s care in the United States—but only for certain patients. Here’s who qualifies, what Medicare covers, how MRI safety monitoring works, and what families should realistically expect.
Federal breach data show ransomware continues to disrupt U.S. hospitals, affecting patient care and exposing medical records. Here’s what that means for your health, privacy, and what you can do if your data are compromised.
If you’re 50 to 80 and have a significant smoking history, you may qualify for annual low-dose CT lung cancer screening. Here’s what the evidence shows, who is eligible, what the trade-offs are, and how insurance coverage works in 2026.
A major Cochrane review finds that spinal manipulation offers modest relief for chronic low back pain—about similar to exercise and other recommended non-drug treatments. Here’s what that means for patients, safety, Medicare coverage, and when to seek urgent care.
Colorectal cancer screening now starts at age 45 for most adults. Here’s what current U.S. guidelines say, how stool tests compare with colonoscopy, what happens after a positive result, and what insurance and Medicare typically cover.
FDA-approved anti-amyloid drugs like lecanemab can modestly slow early Alzheimer’s disease—but they are not cures. Here’s who qualifies, what the clinical trials showed, the real risks, and how Medicare coverage works in 2026.
Most women 65 and older should be screened for osteoporosis, even if they feel fine. Here’s what the current U.S. Preventive Services Task Force recommendation says, what a DXA scan measures, and how insurance coverage works.
The U.S. Preventive Services Task Force has updated its guidance on screening for iron deficiency anemia. Here’s what the new grades mean for infants, pregnant people, and adults—and how they affect preventive care coverage under federal law.
Blood in the urine—whether you can see it or not—should never be ignored. Here’s what hematuria can mean, when it may signal bladder cancer, how doctors evaluate it, and when to seek urgent care.
If you have asthma, federal health officials consider you at higher risk for complications from flu and COVID-19, and some groups face higher RSV risk. Here’s what the 2025–2026 respiratory virus season means for vaccines, action plans, and when to seek care.
Medicare Advantage plans and other insurers increasingly use algorithms to review prior authorization and claims. Federal watchdog findings and new CMS rules clarify what’s allowed, what isn’t, and what rights patients have when care is denied.
AI tools are increasingly used in U.S. hospitals and clinics, but not all of them are regulated the same way. Here’s how the FDA oversees AI-enabled medical devices, what clearance really means, and what patients should ask when AI is involved in their care.
A surge of FDA-approved biosimilars for adalimumab and a redesigned Medicare Part D benefit with a $2,000 annual out-of-pocket cap are reshaping how Americans with arthritis pay for biologic drugs in 2026. Here’s what that means for your costs, coverage, and care decisions.
End of content
End of content
